← Back to all trials
Not Yet Recruiting
NCT05642026
INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures
Conditions: Rib Fractures
Sex: All
Ages: 18 Years – N/A
Phase: PHASE4
Enrollment: 180
Sponsor: Zachary Warriner
Location: United States
Summary
This is a prospective, randomized, non-blinded study comparing CINB plus medical therapy versus standard medical care (non-steroidals and opioids intravenous/oral inpatient and oral outpatient) alone for patients with multiple rib fractures.
The objective of this study is to analyze the effect of continuous intercostal nerve block (CINB) in the treatment of patients admitted to the adult trauma service with rib fractures.
The effectiveness of CINB as adjunctive treatment will be compared to standard medical therapy involving nonsteroidal and intravenous/oral opioid medications.
Eligibility Criteria
Inclusion Criteria:Subjects will be at least 18 years oldSubjects will have 2 or more identified rib fracturesSubjects will be willing to provide informed consent for procedureSubjects will be identified as appropriate for initiation of continuous nerve block therapy for treatment of rib fracture associated pain.Exclusion Criteria:Documented allergy to study medicationEpidural catheter usePrisonersRefusal of CINB therapy
Source: ClinicalTrials.gov (NCT05642026). StuddyBuddy aggregates publicly available trial information.